These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7658357)

  • 1. Comparison of L-carnitine pharmacokinetics with and without baseline correction following administration of single 20-mg/kg intravenous dose.
    Sahajwalla CG; Helton ED; Purich ED; Hoppel CL; Cabana BE
    J Pharm Sci; 1995 May; 84(5):634-9. PubMed ID: 7658357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers.
    Sahajwalla CG; Helton ED; Purich ED; Hoppel CL; Cabana BE
    J Pharm Sci; 1995 May; 84(5):627-33. PubMed ID: 7658356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.
    Harper P; Elwin CE; Cederblad G
    Eur J Clin Pharmacol; 1988; 35(1):69-75. PubMed ID: 3220097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects.
    Harper P; Elwin CE; Cederblad G
    Eur J Clin Pharmacol; 1988; 35(5):555-62. PubMed ID: 3234464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of intravenously administered carnitine in haemodialysed children.
    Glöggler A; Bulla M; Fürst P
    J Pharm Biomed Anal; 1990; 8(5):411-4. PubMed ID: 2081201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of L-carnitine.
    Evans AM; Fornasini G
    Clin Pharmacokinet; 2003; 42(11):941-67. PubMed ID: 12908852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic model for L-carnitine in patients receiving haemodialysis.
    Fornasini G; Upton RN; Evans AM
    Br J Clin Pharmacol; 2007 Sep; 64(3):335-45. PubMed ID: 17506778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.
    Marzo A; Arrigoni Martelli E; Urso R; Rocchetti M; Rizza V; Kelly JG
    Eur J Clin Pharmacol; 1989; 37(1):59-63. PubMed ID: 2591464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
    Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man.
    Segre G; Bianchi E; Corsi M; D'Iddio S; Ghirardi O; Maccari F
    Arzneimittelforschung; 1988 Dec; 38(12):1830-4. PubMed ID: 3245856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dose size on the pharmacokinetics of intravenous hydrocortisone during endogenous hydrocortisone suppression.
    Toothaker RD; Welling PG
    J Pharmacokinet Biopharm; 1982 Apr; 10(2):147-56. PubMed ID: 7120045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and safety of l-carnitine infused i.v. in healthy subjects.
    Uematsu T; Itaya T; Nishimoto M; Takiguchi Y; Mizuno A; Nakashima M; Yoshinobu K; Hasebe T
    Eur J Clin Pharmacol; 1988; 34(2):213-6. PubMed ID: 3383994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.
    Rebouche CJ
    Ann N Y Acad Sci; 2004 Nov; 1033():30-41. PubMed ID: 15591001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPLC determination and pharmacokinetics of endogenous acetyl-L-carnitine (ALC) in human volunteers orally administered a single dose of ALC.
    Kwon OS; Chung YB
    Arch Pharm Res; 2004 Jun; 27(6):676-81. PubMed ID: 15283472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and organ distribution of liposome-encapsulated L-carnitine in rats.
    Jäger W; Koch HP
    Arzneimittelforschung; 1993 Sep; 43(9):974-7. PubMed ID: 8240461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Carnitine on Valproic Acid Pharmacokinetics in Rats.
    Katayama H; Mizukami K; Yasuda M; Hatae T
    J Pharm Sci; 2016 Oct; 105(10):3199-3204. PubMed ID: 27499337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and pharmacokinetic profile of levofloxacin following intravenous, intramuscular and oral administration in turkeys.
    Aboubakr M; Uney K; Elmas M
    Br Poult Sci; 2014 Feb; 55(1):115-9. PubMed ID: 24735473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits.
    Groll AH; Mickiene D; Petraitis V; Petraitiene R; Kelaher A; Sarafandi A; Wuerthwein G; Bacher J; Walsh TJ
    J Antimicrob Chemother; 2005 Nov; 56(5):899-907. PubMed ID: 16172108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients.
    Suzuki A; Sakai Y; Hashimoto K; Osawa H; Tsuruoka S
    Ren Fail; 2018 Nov; 40(1):196-200. PubMed ID: 29616582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.